Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

GMP Audit Concern: SOPs Lacking Cross-References Between QMS Modules

Posted on By

GMP Audit Concern: SOPs Lacking Cross-References Between QMS Modules How Missing Cross-References Between QMS SOPs Can Undermine GMP Compliance Introduction to the Audit Finding 1. Identifying the Issue Quality Management Systems (QMS) rely on interlinked processes such as deviations, CAPAs, change controls, audits, and complaints. However, SOPs for these modules often lack cross-references, resulting in…

Read More “GMP Audit Concern: SOPs Lacking Cross-References Between QMS Modules” »

GMP Audit Findings, System Integration

SOP and Electronic Logbook Disconnect: A GMP Compliance Vulnerability

Posted on By

SOP and Electronic Logbook Disconnect: A GMP Compliance Vulnerability Bridging the SOP and Electronic Logbook Gap in GMP Environments Introduction to the Audit Finding 1. Overview of the Gap Many pharmaceutical facilities implement electronic logbooks (e-logbooks) for traceability and operational tracking. However, SOPs governing critical operations often fail to reference or align with these e-logbook…

Read More “SOP and Electronic Logbook Disconnect: A GMP Compliance Vulnerability” »

GMP Audit Findings, System Integration

Inconsistent SOP Integration Across Sites: A Risk to Multi-Site GMP Compliance

Posted on By

Inconsistent SOP Integration Across Sites: A Risk to Multi-Site GMP Compliance Mitigating SOP Inconsistencies in Multi-Site Pharmaceutical Operations Introduction to the Audit Finding 1. Nature of the Compliance Gap In multi-site pharmaceutical operations, standard operating procedures (SOPs) may vary significantly across locations, even for similar processes. These discrepancies often lead to inconsistent practices, data variations,…

Read More “Inconsistent SOP Integration Across Sites: A Risk to Multi-Site GMP Compliance” »

GMP Audit Findings, System Integration

Confusion from Overlapping SOPs: A Hidden Compliance Risk in Pharma

Posted on By

Confusion from Overlapping SOPs: A Hidden Compliance Risk in Pharma Resolving Confusion from Overlapping SOPs in GMP Environments Introduction to the Audit Finding 1. Nature of the Issue In pharmaceutical operations, multiple departments often draft SOPs independently. When different SOPs cover overlapping or identical processes without coordination, it results in conflicting instructions, duplications, and ambiguity….

Read More “Confusion from Overlapping SOPs: A Hidden Compliance Risk in Pharma” »

GMP Audit Findings, System Integration

Integrating Quality Risk Management into SOP Decisions for GMP Compliance

Posted on By

Integrating Quality Risk Management into SOP Decisions for GMP Compliance Why Quality Risk Management Must Be Embedded in SOP Decision-Making Introduction to the Audit Finding 1. Issue Summary Quality Risk Management (QRM) principles are not consistently applied during SOP development, revision, or implementation. This audit finding reveals the disconnect between risk-based thinking and procedural design….

Read More “Integrating Quality Risk Management into SOP Decisions for GMP Compliance” »

GMP Audit Findings, System Integration

Risks of Using Personal SOP Copies: A Hidden Threat to GMP Compliance

Posted on By

Risks of Using Personal SOP Copies: A Hidden Threat to GMP Compliance Why Personal SOP Copies Threaten GMP Compliance Introduction to the Audit Finding 1. Description of the Gap Personnel accessing Standard Operating Procedures (SOPs) from uncontrolled personal copies—whether printouts or saved files—poses a serious threat to Good Manufacturing Practice (GMP) compliance. 2. Compliance Consequences…

Read More “Risks of Using Personal SOP Copies: A Hidden Threat to GMP Compliance” »

GMP Audit Findings, Uncontrolled Distribution

Training with Uncontrolled SOP Printouts: A GMP Compliance Failure

Posted on By

Training with Uncontrolled SOP Printouts: A GMP Compliance Failure Why Training Using Uncontrolled SOPs Risks Regulatory Non-Compliance Introduction to the Audit Finding 1. Nature of the Non-Compliance Personnel are trained using uncontrolled SOP printouts, often outdated or lacking approval, which bypasses GMP document control systems. 2. Key Risk Areas Incorrect procedures taught during onboarding or…

Read More “Training with Uncontrolled SOP Printouts: A GMP Compliance Failure” »

GMP Audit Findings, Uncontrolled Distribution

Failure to Recall Obsolete SOPs After Revision: A Hidden GMP Vulnerability

Posted on By

Failure to Recall Obsolete SOPs After Revision: A Hidden GMP Vulnerability Why Obsolete SOPs in Circulation Threaten GMP Compliance Introduction to the Audit Finding 1. Finding Overview Organizations often revise SOPs without establishing a procedure to actively retrieve and recall outdated versions already in use. 2. Compliance Risk Personnel may continue using outdated SOPs, violating…

Read More “Failure to Recall Obsolete SOPs After Revision: A Hidden GMP Vulnerability” »

GMP Audit Findings, Uncontrolled Distribution

Risks of Unrestricted Intranet Access to SOPs: A GMP Weakness

Posted on By

Risks of Unrestricted Intranet Access to SOPs: A GMP Weakness Why Intranet SOPs Without Access Restrictions Violate GMP Standards Introduction to the Audit Finding 1. The Issue Explained Standard Operating Procedures (SOPs) hosted on the company intranet are accessible to all personnel without user authentication or role-based restrictions. 2. GMP Compliance Gap Unauthorized personnel may…

Read More “Risks of Unrestricted Intranet Access to SOPs: A GMP Weakness” »

GMP Audit Findings, Uncontrolled Distribution

Technicians Using Outdated Laminated SOPs: A GMP Documentation Hazard

Posted on By

Technicians Using Outdated Laminated SOPs: A GMP Documentation Hazard How Laminated SOPs Lead to GMP Non-Compliance on the Shop Floor Introduction to the Audit Finding 1. Audit Concern Technicians rely on laminated hardcopies of SOPs that are not updated or recalled after revisions. These outdated versions remain in active use. 2. GMP Risk Old procedures…

Read More “Technicians Using Outdated Laminated SOPs: A GMP Documentation Hazard” »

GMP Audit Findings, Uncontrolled Distribution

Posts pagination

Previous 1 … 9 10 11 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme